
Dyadic International DYAI
$ 0.67
-3.98%
Annual report 2025
added 03-25-2026
Dyadic International DIO Ratio 2011-2026 | DYAI
Annual DIO Ratio Dyadic International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | 161 | 105 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 161 | 105 | 133 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
91.6 | $ 209.63 | -0.71 % | $ 371 B | ||
|
Verastem
VSTM
|
403 | $ 4.99 | -5.77 % | $ 346 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Avid Bioservices
CDMO
|
102 | - | - | $ 789 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
46.7 | $ 12.36 | -11.46 % | $ 1.88 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Xeris Pharmaceuticals
XERS
|
501 | $ 5.41 | -2.87 % | $ 868 M | ||
|
22nd Century Group
XXII
|
114 | $ 2.41 | -18.03 % | $ 444 K | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M |